Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease

Neuroscience Research

Volumn 62, Issue 3, 2008, Pages 206-209

  Cansev, Mehmet ^a,b   Ulus, Ismail H ^a,b   Wang, Lei ^a   Maher, Timothy J ^a,c   Wurtman, Richard J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ULUDAG UNIVERSITY   (Turkey)

^c MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Docosahexaenoic acid; Dopamine; Parkinson's disease; Synapse; Tyrosine hydroxylase activity; Uridine

Indexed keywords

DEXAMPHETAMINE; DOCOSAHEXAENOIC ACID; DOPAMINE; OXIDOPAMINE; PHOSPHOLIPID; SYNAPSIN I; TYROSINE 3 MONOOXYGENASE; URIDINE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; ENZYME ACTIVITY; MALE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SYNAPTIC MEMBRANE;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOCOSAHEXAENOIC ACIDS; DOPAMINE; FUNCTIONAL LATERALITY; INJECTIONS; MALE; NEOSTRIATUM; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR; SYMPATHOLYTICS; TYROSINE 3-MONOOXYGENASE; URIDINE;

EID: 52949131866     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.07.005     Document Type: Article

References (21)

1. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., and Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. J. Neurol. Sci. 20 (1973) 415-455
2. Bousquet M., Saint-Pierre M., Julien C., Salem Jr. N., Cicchetti F., and Calon F. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J. 22 (2008) 1213-1225
3. Cansev M., Watkins C.J., van der Beek E.M., and Wurtman R.J. Oral uridine 5′monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Res. 1058 (2005) 101-108
4. Cansev M. Involvement of uridine-nucleotide-stimulated P2Y receptors in neuronal growth and function. Cent. Nerv. Syst. Agents Med. Chem. 7 (2007) 223-229
5. Cansev M., and Wurtman R.J. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 148 (2007) 421-431
6. Darios F., and Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 440 (2006) 813-817
7. DeGeorge J.J., Nariai T., Yamazaki S., Williams W.M., and Rapoport S.I. Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats. J. Neurochem. 56 (1991) 352-355
8. Ferreira A., and Rapoport M. The synapsins: beyond the regulation of neurotransmitter release. Cell. Mol. Life Sci. 59 (2002) 589-595
9. Hefti F., Melamed E., and Wurtman R.J. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res. 195 (1980) 123-137
10. Kennedy E.M., and Weiss S.B. The function of cytidine coenzymes in the biosynthesis of phospholipids. J. Biol. Chem. 222 (1956) 193-214
11. Kirik D., Rosenblad C., and Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152 (1998) 259-277
12. Millington W.R., and Wurtman R.J. Choline administration elevates brain phosphorylcholine levels. J. Neurochem. 38 (1982) 1748-1752
13. Olds M.E., Jacques D.B., and Kopyov O. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions. Synapse 59 (2006) 532-544
14. Pooler A.M., Guez D.H., Benedictus R., and Wurtman R.J. Uridine enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma cells. Neuroscience 134 (2005) 207-214
15. Ross B.M., Moszczynska A., Blusztajn J.K., Sherwin A., Lozano A., and Kish S.J. Phospholipid biosynthetic enzymes in human brain. Lipids 32 (1997) 351-358
16. Sakamoto T., Cansev M., and Wurtman R.J. Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 1182 (2007) 50-59
17. Ulus I.H., and Wurtman R.J. Choline administration: activation of tyrosine hydroxylase in dopaminergic neurons of rat brain. Science 194 (1976) 1060-1061
18. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367 (1971) 69-93
19. Wang L., Pooler A.M., Albrecht M.A., and Wurtman R.J. Dietary uridine-5′-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. J. Mol. Neurosci. 27 (2005) 137-145
20. Wurtman R.J., Ulus I.H., Cansev M., Watkins C.J., Wang L., and Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 1088 (2006) 83-92
21. Wurtman, R.J., Cansev, M., Ulus, I.H., in press. Choline and its products acetylcholine and phosphatidylcholine. In: Lajtha, A. (Ed.), Neural Lipids, Handbook of Neurochemistry and Molecular Neurobiology, vol. 8. Springer-Verlag, Berlin-Heidelberg.